{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:06:54Z","timestamp":1782227214784,"version":"3.54.5"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Primary biliary cholangitis (PBC) frequently coexists with other autoimmune diseases, including celiac disease (CeD). Although the prevalence of CeD is high among cohorts with PBC, few studies have directly compared this prevalence to those among individuals with other liver diseases (OLD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To compare the prevalence of CeD between a cohort with PBC and a cohort with OLD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Retrospective study from January 2013 to December 2016. All consecutive patients with an anti-transglutaminase (tTG) assay requested by a hepatologist and a diagnosis of chronic liver disease were included. CeD diagnosis was confirmed by duodenal biopsies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We included 399 consecutive patients (53.1 years SD 14.0, 54.1% women), notably 51 individuals with PBC and 348 individuals with OLD. PBC group included significantly more women (90.2% versus 48.9% P &amp;lt; 0.0001). The prevalence of CeD was higher in the group with PBC compared to the group with OLD (11.8 versus 2.9%, P &amp;lt; 0.003). In the OLD group, the prevalence of CeD was comparable regardless of the etiologic subgroup (nonalcoholic steatohepatitis 2.7% versus alcoholic liver disease 4.3%, versus viral 1.5% versus other autoimmune liver diseases 3.3%, NS). The presence of gastrointestinal symptoms at the time of the tTG assay was comparable between PBC and OLD groups (31.4 versus 29.6%, NS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>There is a higher prevalence of CeD in the PBC group compared to other liver diseases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jcag\/gwz039","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T20:07:07Z","timestamp":1576526827000},"page":"44-47","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence of Celiac Disease in Patients with Primary Biliary Cholangitis"],"prefix":"10.1093","volume":"4","author":[{"given":"Kashi","family":"Callichurn","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), CRCHUM, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Cvetkovic","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), CRCHUM, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Therrien","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), CRCHUM, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Vincent","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), CRCHUM, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Olivier","family":"H\u00e9tu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), CRCHUM, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Bouin","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), CRCHUM, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"key":"2021022211282483100_CIT0001","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL clinical practice guidelines: The diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J Hepatol"},{"issue":"5","key":"2021022211282483100_CIT0002","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ajg.2013.79","article-title":"ACG clinical guidelines: Diagnosis and management of celiac disease","volume":"108","author":"Rubio-Tapia","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"43","key":"2021022211282483100_CIT0003","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.3748\/wjg.v18.i43.6255","article-title":"Celiac disease markers in patients with liver diseases: A single center large scale screening study","volume":"18","author":"Drastich","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2021022211282483100_CIT0004","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12016-014-8427-x","article-title":"Extrahepatic autoimmune conditions associated with primary biliary cirrhosis","volume":"48","author":"Floreani","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"2021022211282483100_CIT0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/gut.42.1.120","article-title":"The association between primary biliary cirrhosis and coeliac disease: A study of relative prevalences","volume":"42","author":"Kingham","year":"1998","journal-title":"Gut"},{"issue":"3","key":"2021022211282483100_CIT0006","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1586\/egh.13.5","article-title":"Gut-liver axis: An immune link between celiac disease and primary biliary cirrhosis","volume":"7","author":"Volta","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"2","key":"2021022211282483100_CIT0007","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.dld.2015.11.013","article-title":"Celiac disease-related hepatic injury: Insights into associated conditions and underlying pathomechanisms","volume":"48","author":"Marciano","year":"2016","journal-title":"Dig Liver Dis"},{"issue":"5","key":"2021022211282483100_CIT0008","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3748\/wjg.v23.i5.776","article-title":"To screen or not to screen? Celiac antibodies in liver diseases","volume":"23","author":"Narciso-Schiavon","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2021022211282483100_CIT0009","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1309\/AJCPDOMY5RI5TPMN","article-title":"The liver in celiac disease: Clinical manifestations, histologic features, and response to gluten-free diet in 30 patients","volume":"136","author":"Mounajjed","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"2021022211282483100_CIT0010","article-title":"Discordance between serology and histology for celiac disease in a cohort with coexisting liver disorders","author":"Cvetkovic","year":"2019","journal-title":"Journal of the Canadian Association of Gastroenterology"},{"issue":"5","key":"2021022211282483100_CIT0011","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/gut.44.5.736","article-title":"Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data","volume":"44","author":"Sorensen","year":"1999","journal-title":"Gut"},{"issue":"2","key":"2021022211282483100_CIT0012","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/gut.43.2.300","article-title":"Co-screening for primary biliary cirrhosis and coeliac disease. Association between primary biliary cirrhosis and coeliac disease","volume":"43","author":"Dickey","year":"1998","journal-title":"Gut"},{"issue":"8","key":"2021022211282483100_CIT0013","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1155\/2000\/934709","article-title":"Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis","volume":"14","author":"Gillett","year":"2000","journal-title":"Can J Gastroenterol"},{"issue":"3","key":"2021022211282483100_CIT0014","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/hep.510230307","article-title":"Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex","volume":"23","author":"Moteki","year":"1996","journal-title":"Hepatology"},{"issue":"3","key":"2021022211282483100_CIT0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-0034-1383726","article-title":"Environmental factors in primary biliary cirrhosis","volume":"34","author":"Juran","year":"2014","journal-title":"Semin Liver Dis"},{"issue":"6333","key":"2021022211282483100_CIT0016","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.aah5298","article-title":"Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease","volume":"356","author":"Bouziat","year":"2017","journal-title":"Science"},{"issue":"5","key":"2021022211282483100_CIT0017","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cgh.2016.10.033","article-title":"Factors that increase risk of celiac disease autoimmunity after a gastrointestinal infection in early life","volume":"15","author":"Kemppainen","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"2021022211282483100_CIT0018","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.jaci.2017.02.015","article-title":"Circulating gluten-specific FOXP3+CD39+ regulatory T cells have impaired suppressive function in patients with celiac disease","volume":"140","author":"Cook","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"2021022211282483100_CIT0019","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1038\/cti.2016.58","article-title":"Coeliac disease: A unique model for investigating broken tolerance in autoimmunity","volume":"5","author":"Hardy","year":"2016","journal-title":"Clin Transl Immunology"},{"issue":"3","key":"2021022211282483100_CIT0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cld.2018.03.001","article-title":"Changes in the epidemiology of primary biliary cholangitis","volume":"22","author":"Lleo","year":"2018","journal-title":"Clin Liver Dis"},{"key":"2021022211282483100_CIT0021","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","article-title":"Global prevalence of celiac disease: Systematic review and meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2\u20133","key":"2021022211282483100_CIT0022","doi-asserted-by":"crossref","first-page":"J187","DOI":"10.1016\/j.jaut.2011.11.012","article-title":"The X chromosome and immune associated genes","volume":"38","author":"Bianchi","year":"2012","journal-title":"J Autoimmun"},{"issue":"10","key":"2021022211282483100_CIT0023","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1023\/A:1026650118759","article-title":"Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis","volume":"43","author":"Volta","year":"1998","journal-title":"Dig Dis Sci"},{"issue":"1","key":"2021022211282483100_CIT0024","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jcla.20047","article-title":"High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue tranglutaminase autoantibodies","volume":"19","author":"Villalta","year":"2005","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"2021022211282483100_CIT0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1478-3231.2008.01681.x","article-title":"Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation","volume":"28","author":"Rubio-Tapia","year":"2008","journal-title":"Liver Int"},{"issue":"7","key":"2021022211282483100_CIT0026","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.cgh.2007.12.002","article-title":"Autoimmune liver disease associated with celiac disease in childhood: A multicenter study","volume":"6","author":"Caprai","year":"2008","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Journal of the Canadian Association of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcag\/article-pdf\/4\/1\/44\/36333272\/gwz039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcag\/article-pdf\/4\/1\/44\/36333272\/gwz039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T11:29:54Z","timestamp":1613993394000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcag\/article\/4\/1\/44\/5694304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,2]]},"published-print":{"date-parts":[[2021,2,22]]}},"URL":"https:\/\/doi.org\/10.1093\/jcag\/gwz039","relation":{},"ISSN":["2515-2084","2515-2092"],"issn-type":[{"value":"2515-2084","type":"print"},{"value":"2515-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,1,2]]}}}